[8-K] Veritone, Inc. Reports Material Event

Rhea-AI Filing Summary

Veritone, Inc. announced a registered direct offering of 12,864,494 shares of common stock at $5.83 per share, for expected gross proceeds of approximately $75.0 million. The transaction is expected to close on or about October 17, 2025, subject to customary closing conditions.

The company plans to use net proceeds, together with existing cash and cash equivalents, for working capital and general corporate purposes including capital expenditures, debt service, and repayment of indebtedness. The offering is being made under an effective Form S-3 shelf with a related base prospectus and prospectus supplement.

Insights

Capital markets analyst

Primary raise of 12.86M shares at $5.83 targets ~$75M gross.

Veritone entered a registered direct offering for 12,864,494 common shares at an offering price of $5.83 per share, implying expected gross proceeds of about $75.0 million. Closing is anticipated on October 17, 2025, contingent on customary conditions.

Proceeds are earmarked for working capital and general corporate purposes, including capital expenditures, debt service, and repayment of indebtedness. The transaction is issued off an effective Form S-3 shelf with a prospectus supplement, streamlining execution.

Investor impact will depend on final closing and the deployment of funds. Subsequent disclosures may detail net proceeds after expenses and any debt repayment completed with the raise.

false 0001615165 0001615165 2025-10-15 2025-10-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 15, 2025

Veritone, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware		001-38093		47-1161641
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

5291 California Avenue, Suite 350 Irvine, California		92617
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (888) 507-1737

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		VERI		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Registered Direct Offering

On October 15, 2025, Veritone, Inc. (the “Company”) entered into a securities purchase agreement (the “RDO Purchase Agreement”) with the purchasers named therein (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers, in a registered direct offering (the “Registered Direct Offering”), 12,864,494 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”). The offering price of each Share is $5.83 per share (the “Offering Price”). The gross proceeds to the Company from the Registered Direct Offering are expected to be approximately $75.0 million, before deducting offering expenses payable by the Company.

The Registered Direct Offering is expected to close on or about October 17, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the Registered Direct Offering, together with its existing cash and cash equivalents, for working capital and general corporate purposes including, but not limited to, capital expenditures, debt service and repayment of indebtedness.

The RDO Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, including for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the RDO Purchase Agreement were made only for the purposes of such agreement and as of the specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties.

The Registered Direct Offering was made pursuant to the Company’s effective registration statement on Form S-3 (Registration Statement No. 333-280148) that was originally filed with the Securities and Exchange Commission (the “SEC”) on June 12, 2024, and that became effective on June 21, 2024 and a related base prospectus and prospectus supplement (the “Prospectus Supplement”) thereunder.

The foregoing description of the RDO Purchase Agreement does not purport to be complete and is qualified in its entirety by the full text of the form of RDO Purchase Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated by reference herein.

Item 7.01 Regulation FD Disclosure.

On October 16, 2025, the Company issued a press release announcing the terms of the Registered Direct Offering, a copy of which is furnished as Exhibit 99.1 hereto.

The information set forth in this Item 7.01 and contained in the press release furnished as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is not incorporated by reference into any of the Company’s filings under the Securities Act or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
10.1†		Form of Securities Purchase Agreement, by and among Veritone, Inc. and the Purchasers, dated October 15, 2025.
99.1		Press Release of Veritone, Inc. dated October 16, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

† The exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K under the Securities Act of 1933, as amended. The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon request.

Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements, including, without limitation, statements relating to the Company’s expectations regarding the completion and timing of the Registered Direct Offering, the satisfaction of customary closing conditions related to the Registered Direct Offering, the proceeds that the Company expects to receive from the Registered Direct Offering and the intended use of proceeds from the Registered Direct Offering. Forward-looking statements are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements speak only as of the date they are made and, except for the Company’s ongoing obligations under the U.S. federal securities laws, the Company undertakes no obligation to update any forward-looking statement.

Forward-looking statements are subject to known and unknown risks and uncertainties and are based on estimates and assumptions that are subject to change or revision. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including, without limitation, market conditions and the Company’s ability to satisfy the closing conditions to the Registered Direct Offering, as well as risks and uncertainties inherent in the Company’s business. For a discussion of these and other factors, please refer to the risk factors included in the Company’s Annual Report on Form 10-K, and the Company’s Quarterly Reports on Form 10-Q and other periodic reports filed from time to time with the SEC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				Veritone, Inc.
Date: October 16, 2025				By:		/s/ Michael L. Zemetra
						Michael L. Zemetra
						Executive Vice President, Chief Financial Officer and Treasurer

FAQ

What did Veritone (VERI) announce?

Veritone entered a registered direct offering to sell 12,864,494 shares of common stock at $5.83 per share.

How much will Veritone (VERI) raise from the offering?

The company expects approximately $75.0 million in gross proceeds, before offering expenses.

When is the Veritone (VERI) offering expected to close?

Closing is expected on or about October 17, 2025, subject to customary conditions.

How will Veritone (VERI) use the proceeds?

Net proceeds are intended for working capital and general corporate purposes, including capital expenditures, debt service, and repayment of indebtedness.

Under what registration is the Veritone (VERI) offering being made?

It is being made under an effective Form S-3 shelf (No. 333-280148) with a base prospectus and a prospectus supplement.